Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #203 on Algernon Pharmaceuticals Inc (AGNPF)
shell3
10/08/16 5:55 AM
#204 RE: ILuvblo2 #203
The Company has also continued to develop the FAIMS technology and has completed the V2 prototype of the device significantly reducing the size and complexity of the design. The bench top testing of this newest FAIMS device will be conducted this month.
SO75
10/08/16 9:50 AM
#206 RE: ILuvblo2 #203